Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Research and development | 45M | 56M |
| Selling, general and administrative | 16M | 19M |
| Operating expenses | 61M | 75M |
| Operating income | −61M | −74M |
| Net income | −61M | −71M |
| Earnings per share | −1.32 | −1.63 |
| Earnings per share, diluted | −1.33 | −1.63 |
| Weighted average shares | 46M | 43M |
| Weighted average shares, diluted | 47M | 44M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 46M | 57M | 66M | 78M | 92M | 111M | 123M | 135M |
| Current assets | 49M | 59M | 68M | 80M | 94M | 113M | 126M | 139M |
| Property, plant and equipment | 4M | 5M | 5M | 5M | 6M | 6M | 7M | 7M |
| Total assets | 58M | 69M | 80M | 93M | 107M | 127M | 140M | 154M |
| Current liabilities | 39M | 36M | 18M | 15M | 12M | 15M | 12M | 11M |
| Total liabilities | 46M | 45M | 50M | 51M | 50M | 54M | 51M | 50M |
| Equity | 12M | 25M | 30M | 41M | 57M | 73M | 89M | 104M |
| Shares outstanding | 49M | 49M | 47M | 45M | 45M | 45M | 44M | 44M |
| Shares issued | 49M | 49M | 47M | 45M | 45M | 45M | 44M | 44M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −60M | −56M |
| Depreciation and amortisation | 2M | 2M |
| Share-based compensation | 6M | 9M |
| Capital expenditure | 0 | 254,000 |
| Investing cash flow | 0 | −254,000 |
| Financing cash flow | 6M | 13M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator